Dr Luis Paz-Ares presents in a press conference at ESMO 2017 data from the double blind phase III PACIFIC trial of durvalumab as sequential treatment in patients with locally-advanced, unresectable lung cancer. Dr Paz-Ares states that...
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2fawWEg
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,